Innovation is the Best Medicine: How CEO Shane Schaffer and Cingulate Developed “Precision Timed Release,” a New Drug Delivery Platform for ADHD

Skip to main navigation close search window CING | Nasdaq Listed Header Menu Company About Cingulate® Senior Management Board of Directors Scientific Advisors Pipeline Pipeline Overview ADHD Patient Experience Patient Experience Treatments Cingulate® Technology Publications CTx-1301: ADHD CTx-1302: ADHD CTX-2103: Anxiety Partners Investors Webcasts & Presentations Corporate Governance Financials & Filings SEC Filings Analyst Coverage Stock Information Stock Quote & Chart Historic Price Lookup Investment Calculator IR Resources Investor FAQs Email Alerts Contact IR Careers Press Releases Cingulate In the News Contact us Header Social Twitter LinkedIn Facebook Youtube Header Menu Company About Cingulate® Senior Management Board of Directors Scientific Advisors Pipeline Pipeline Overview ADHD Patient Experience Patient Experience Treatments Cingulate® Technology Publications CTx-1301: ADHD CTx-1302: ADHD CTX-2103: Anxiety Partners Investors Webcasts & Presentations Corporate Governance Financials & Filings SEC Filings Analyst Coverage Stock Information Stock Quote & Chart Historic Price Lookup Investment Calculator IR Resources Investor FAQs Email Alerts Contact IR Careers Press Releases Cingulate In the News Contact us back to top close search window Search: search submit button Press Release Jun 25, 2026 Innovation is the Best Medicine: How CEO Shane Schaffer and Cingulate Developed “Precision Timed Release,” a New Drug Delivery Platform for ADHD Innovation is the Best Medicine: How CEO Shane Schaffer and Cingulate Developed… Twitter LinkedIn Facebook Youtube Contact us 1901 W 47th Place Kansas City 66205 [email protected] 913-942-2300 © 2026 Cingulate ® | PRIVACY POLICY Notifications